© LB Pharmaceuticals., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.
Piero Poli is the President, principal owner and Chief Executive Officer of Rivopharm SA, a pharmaceutical company that develops, manufactures and markets pharmaceutical products in the generic field worldwide. Mr. Poli has been involved in the pharmaceutical field for his entire career, and has a long history of success in new product development and growing market share in both developed and emerging markets throughout the world.